From SBA-backed asset purchases to MSO arrangements and earnouts — understand the deal structures that close pain clinic transactions in the $1M–$5M revenue range.
Acquiring a pain management clinic involves navigating a uniquely complex intersection of healthcare regulatory law, physician licensing requirements, and standard M&A financing mechanics. Unlike a typical business acquisition, pain clinic deals must account for corporate practice of medicine (CPOM) restrictions, DEA registration continuity, payer contract assignability, and the outsized role of the founding physician in driving revenue. The right deal structure balances the buyer's need for regulatory compliance and downside protection with the seller's desire for a clean exit and fair recognition of practice goodwill. Most lower middle market pain clinic transactions in the $1M–$5M revenue range fall into one of three structural frameworks: an SBA-backed asset purchase with seller financing, a stock purchase with performance-based earnouts tied to physician retention, or a Management Services Organization (MSO) arrangement that allows non-physician buyers to legally acquire the business operations while a licensed physician entity retains clinical control. Each structure carries distinct advantages depending on the buyer's background, the practice's regulatory history, and the state's CPOM rules.
Find Pain Management Clinic Businesses For SaleAsset Purchase with SBA 7(a) Financing
The buyer acquires specific assets of the pain clinic — including equipment, patient records, lease rights, and practice goodwill — rather than the legal entity itself. The majority of the purchase price is financed through an SBA 7(a) loan, with the seller typically carrying 10–20% of the price in a subordinated seller note. This is the most common structure for independent physician-owned pain clinics changing hands to individual buyers or small operator groups.
Pros
Cons
Best for: First-time healthcare buyers, entrepreneurial physicians acquiring an established practice, or SBA-eligible operators with a licensed physician partner lined up to assume clinical oversight post-close.
Stock Purchase with Earnout
The buyer acquires the equity of the physician-owned professional corporation (PC) or LLC, assuming all assets, liabilities, payer contracts, and existing DEA registration. A portion of the total purchase price — typically 15–25% — is structured as an earnout tied to revenue or EBITDA performance over a 12–24 month post-close period, often contingent on key physician retention. This structure is favored by strategic acquirers and PE-backed groups that can absorb legacy risk in exchange for deal continuity.
Pros
Cons
Best for: PE-backed groups, multi-specialty clinic networks, or experienced healthcare operators acquiring a practice with a clean regulatory history, multiple employed physicians, and stable payer contracts where continuity is the primary priority.
MSO Structure (Management Services Organization)
A non-physician buyer forms a Management Services Organization that acquires all non-clinical business assets — including equipment, real estate or lease rights, billing infrastructure, and brand — and enters into a long-term Management Services Agreement (MSA) with a physician-owned Professional Corporation (PC) that retains clinical and prescribing authority. The MSO charges the PC a management fee (typically 40–60% of gross collections) in exchange for handling all administrative functions. This structure is specifically designed to comply with corporate practice of medicine laws in states that prohibit non-physicians from owning or controlling medical practices.
Pros
Cons
Best for: Private equity firms, non-physician entrepreneurs, search fund operators with a physician partner, or strategic acquirers building a multi-site pain management platform in states with active CPOM enforcement such as California, Texas, New York, or Florida.
Solo Physician Practice — Retiring Owner, Clean DEA History
$2,100,000
SBA 7(a) Loan: $1,470,000 (70%) | Seller Note: $315,000 (15%) | Buyer Equity: $315,000 (15%)
SBA loan at prime + 2.75% over 10 years; seller note subordinated, interest-only for 24 months at 6%, then fully amortizing over 36 months; seller stays on as a part-time clinical consultant for 12 months post-close to support patient transition
Two-Physician Group Practice — PE-Backed Strategic Acquirer, Stock Purchase
$4,500,000
Senior Debt / Equity: $2,925,000 (65%) | Earnout: $900,000 (20%) | Seller Rollover Equity: $675,000 (15%)
Earnout paid in two tranches: $450,000 at 12 months if TTM revenue exceeds $3.2M, $450,000 at 24 months if TTM revenue exceeds $3.5M; both physicians sign 3-year employment agreements with non-competes; sellers roll 15% equity into acquirer's platform at equivalent valuation
Non-Physician Buyer — MSO Acquisition in CPOM State
$1,800,000 (non-clinical assets only)
Senior Bank Debt: $1,260,000 (70%) | Seller Financing: $270,000 (15%) | Buyer Equity: $270,000 (15%)
MSO acquires equipment, lease, brand, and billing systems; 10-year MSA executed with physician PC; management fee set at 45% of gross collections; physician PC owner retains nominal clinical equity and signs 5-year non-compete; seller note at 6.5% over 4 years, subordinated to senior lender
Find Pain Management Clinic Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
Yes, but the structure depends heavily on the state. Many states have corporate practice of medicine (CPOM) laws that prohibit non-physicians from directly owning or controlling a medical practice. In these states, non-physician buyers typically use an MSO structure: a non-physician entity acquires all non-clinical business assets and contracts with a physician-owned Professional Corporation under a Management Services Agreement. The MSO controls the economics and operations while the physician PC retains nominal clinical ownership. States like California, Texas, and New York have strict CPOM rules, while others are more permissive. Always engage a healthcare attorney licensed in the relevant state before structuring a non-physician acquisition.
No. A DEA registration is issued to a specific individual or entity and cannot be transferred in an asset purchase. In an asset sale, the new owner or incoming physician must apply for a new DEA registration, which can take 4–8 weeks and creates a gap in the ability to prescribe controlled substances. Stock purchases preserve the existing entity's DEA registration, which is one reason strategic buyers in this space often prefer stock deals for practices with active controlled substance prescribing. Buyers should plan for this gap and coordinate with the seller on bridge prescribing coverage during the transition.
Earnouts in pain clinic deals are typically structured over 12–24 months and represent 15–25% of the total purchase price. They are most commonly tied to cash collections, net revenue, or EBITDA relative to a trailing twelve-month baseline at close. A well-structured earnout will include two or more measurement dates, clearly defined calculation methodologies, audit rights for the seller, and explicit protections against buyer actions that could artificially suppress performance — such as cutting marketing, reducing physician hours, or changing billing practices. Earnouts tied to physician retention milestones (e.g., the lead physician remains employed and clinically active) are also common in physician-dependent practices.
Yes, pain management clinics are generally SBA 7(a) eligible as healthcare service businesses. SBA loans can finance up to $5M of a qualifying acquisition, making them well-suited for practices in the $1M–$5M revenue range. However, SBA lenders will scrutinize the practice's cash flow coverage (typically requiring a debt service coverage ratio of 1.25x or better), the departing physician's role in revenue generation, and the buyer's relevant healthcare management experience. Practices with heavy opioid prescribing histories, DEA compliance issues, or significant physician key-person dependency may face lender reluctance. SBA loans work best for asset purchases where the buyer has a licensed physician committed to the practice and the financials clearly support the debt load.
Payer contracts are one of the most operationally sensitive components of a pain clinic acquisition. In an asset purchase, contracts typically cannot be assigned without the payer's consent and must be re-credentialed under the new owner's provider numbers — a process that can take 60–120 days per payer and delay post-close cash flow. In a stock purchase, contracts remain with the acquired entity and provider numbers are unchanged, though some payers require change-of-ownership notification. Buyers should obtain a complete payer contract inventory during due diligence, confirm assignability or re-credentialing requirements with each payer, and build a transition cash reserve sufficient to cover 90–120 days of operating expenses to bridge any revenue gap during re-credentialing.
Pain management clinics in the lower middle market typically trade at 3.5x to 6x EBITDA, with the specific multiple driven by several factors: the mix of interventional versus medication management revenue (interventional commands higher multiples), the number and independence of employed physicians, payer mix quality, DEA compliance history, and the transferability of patient relationships. Practices with diversified multi-physician teams, strong commercial payer mix, clean regulatory records, and documented systems that reduce founder dependency will approach the higher end of this range. Single-physician practices with heavy opioid management focus and no ancillary revenue tend to trade at the lower end, sometimes below 4x, due to key-person and regulatory risk.
More Pain Management Clinic Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers